

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.10541031 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.10541031 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 4.67134682 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.67134682 |
| 5 | immunoglobulin mediated immune response (GO:0016064) | 4.65401487 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.63182297 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 4.63182297 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.61313859 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.45795137 |
| 10 | complement activation, alternative pathway (GO:0006957) | 4.42802995 |
| 11 | aromatic amino acid family catabolic process (GO:0009074) | 4.41057629 |
| 12 | negative regulation of fibrinolysis (GO:0051918) | 4.22972437 |
| 13 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.21905776 |
| 14 | protein carboxylation (GO:0018214) | 4.21905776 |
| 15 | kynurenine metabolic process (GO:0070189) | 4.19465078 |
| 16 | indole-containing compound catabolic process (GO:0042436) | 4.19211261 |
| 17 | indolalkylamine catabolic process (GO:0046218) | 4.19211261 |
| 18 | tryptophan catabolic process (GO:0006569) | 4.19211261 |
| 19 | regulation of protein activation cascade (GO:2000257) | 4.13784028 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 4.03611054 |
| 21 | bile acid biosynthetic process (GO:0006699) | 3.98199411 |
| 22 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.96260435 |
| 23 | regulation of complement activation (GO:0030449) | 3.96121561 |
| 24 | alpha-linolenic acid metabolic process (GO:0036109) | 3.95779605 |
| 25 | urea metabolic process (GO:0019627) | 3.95004942 |
| 26 | urea cycle (GO:0000050) | 3.95004942 |
| 27 | tryptophan metabolic process (GO:0006568) | 3.93237809 |
| 28 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.91883096 |
| 29 | plasma lipoprotein particle clearance (GO:0034381) | 3.91697957 |
| 30 | regulation of fibrinolysis (GO:0051917) | 3.85436656 |
| 31 | * response to interferon-beta (GO:0035456) | 3.82819725 |
| 32 | B cell mediated immunity (GO:0019724) | 3.71749427 |
| 33 | glyoxylate metabolic process (GO:0046487) | 3.69867847 |
| 34 | sulfur amino acid catabolic process (GO:0000098) | 3.68917584 |
| 35 | nitrogen cycle metabolic process (GO:0071941) | 3.64644662 |
| 36 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.63224388 |
| 37 | reverse cholesterol transport (GO:0043691) | 3.59011413 |
| 38 | phospholipid efflux (GO:0033700) | 3.54586039 |
| 39 | regulation of cholesterol esterification (GO:0010872) | 3.53511463 |
| 40 | cysteine metabolic process (GO:0006534) | 3.53407334 |
| 41 | positive regulation of interferon-alpha production (GO:0032727) | 3.52418782 |
| 42 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.49491702 |
| 43 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.49144090 |
| 44 | regulation of triglyceride catabolic process (GO:0010896) | 3.46187055 |
| 45 | protein-lipid complex remodeling (GO:0034368) | 3.46140606 |
| 46 | macromolecular complex remodeling (GO:0034367) | 3.46140606 |
| 47 | plasma lipoprotein particle remodeling (GO:0034369) | 3.46140606 |
| 48 | NIK/NF-kappaB signaling (GO:0038061) | 3.44023043 |
| 49 | response to peptidoglycan (GO:0032494) | 3.41054437 |
| 50 | negative regulation of cell killing (GO:0031342) | 3.37170272 |
| 51 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.37170272 |
| 52 | response to type I interferon (GO:0034340) | 3.35082206 |
| 53 | type I interferon signaling pathway (GO:0060337) | 3.34790352 |
| 54 | cellular response to type I interferon (GO:0071357) | 3.34790352 |
| 55 | negative regulation of cholesterol transport (GO:0032375) | 3.34288130 |
| 56 | negative regulation of sterol transport (GO:0032372) | 3.34288130 |
| 57 | aldehyde catabolic process (GO:0046185) | 3.32554637 |
| 58 | positive regulation of antigen processing and presentation (GO:0002579) | 3.31830208 |
| 59 | * negative regulation of viral genome replication (GO:0045071) | 3.31401354 |
| 60 | regulation of interferon-alpha production (GO:0032647) | 3.30671139 |
| 61 | cellular response to interferon-beta (GO:0035458) | 3.29878655 |
| 62 | bile acid metabolic process (GO:0008206) | 3.28958269 |
| 63 | regulation of antigen processing and presentation (GO:0002577) | 3.28591207 |
| 64 | positive regulation of B cell differentiation (GO:0045579) | 3.28385928 |
| 65 | T cell migration (GO:0072678) | 3.26533877 |
| 66 | neutrophil activation involved in immune response (GO:0002283) | 3.22730137 |
| 67 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.22372040 |
| 68 | low-density lipoprotein particle clearance (GO:0034383) | 3.21453018 |
| 69 | detection of bacterium (GO:0016045) | 3.21312591 |
| 70 | homocysteine metabolic process (GO:0050667) | 3.20810514 |
| 71 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.16842672 |
| 72 | cholesterol efflux (GO:0033344) | 3.16644446 |
| 73 | serine family amino acid catabolic process (GO:0009071) | 3.16472465 |
| 74 | aromatic amino acid family metabolic process (GO:0009072) | 3.15428756 |
| 75 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.13444152 |
| 76 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.13444152 |
| 77 | acute-phase response (GO:0006953) | 3.11323096 |
| 78 | complement activation (GO:0006956) | 3.09519789 |
| 79 | triglyceride homeostasis (GO:0070328) | 3.09300393 |
| 80 | acylglycerol homeostasis (GO:0055090) | 3.09300393 |
| 81 | detection of other organism (GO:0098543) | 3.08736811 |
| 82 | fibrinolysis (GO:0042730) | 3.08681899 |
| 83 | negative regulation of interleukin-12 production (GO:0032695) | 3.08233949 |
| 84 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.06515790 |
| 85 | mature B cell differentiation involved in immune response (GO:0002313) | 3.06249565 |
| 86 | regulation of cholesterol storage (GO:0010885) | 3.05809172 |
| 87 | complement activation, classical pathway (GO:0006958) | 3.05575723 |
| 88 | glycine metabolic process (GO:0006544) | 3.04363340 |
| 89 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.04331140 |
| 90 | cellular response to interferon-gamma (GO:0071346) | 3.03867663 |
| 91 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.03309426 |
| 92 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.03309426 |
| 93 | arginine metabolic process (GO:0006525) | 3.02846920 |
| 94 | protein activation cascade (GO:0072376) | 3.02629816 |
| 95 | amino-acid betaine metabolic process (GO:0006577) | 3.02469070 |
| 96 | ethanol oxidation (GO:0006069) | 2.99865452 |
| 97 | lymphocyte chemotaxis (GO:0048247) | 2.99348923 |
| 98 | plasma lipoprotein particle assembly (GO:0034377) | 2.98940857 |
| 99 | myeloid dendritic cell activation (GO:0001773) | 2.97735767 |
| 100 | T-helper 1 type immune response (GO:0042088) | 2.97212878 |
| 101 | tyrosine metabolic process (GO:0006570) | 2.97143896 |
| 102 | myeloid dendritic cell differentiation (GO:0043011) | 2.96589045 |
| 103 | NAD biosynthetic process (GO:0009435) | 2.96467819 |
| 104 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.94602155 |
| 105 | lysine metabolic process (GO:0006553) | 2.93202605 |
| 106 | lysine catabolic process (GO:0006554) | 2.93202605 |
| 107 | positive regulation of coagulation (GO:0050820) | 2.87631989 |
| 108 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.87024660 |
| 109 | imidazole-containing compound metabolic process (GO:0052803) | 2.86985334 |
| 110 | regulation of humoral immune response (GO:0002920) | 2.86785681 |
| 111 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.86400092 |
| 112 | low-density lipoprotein particle remodeling (GO:0034374) | 2.86297386 |
| 113 | cofactor catabolic process (GO:0051187) | 2.85776366 |
| 114 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.85338611 |
| 115 | alpha-amino acid catabolic process (GO:1901606) | 2.85089628 |
| 116 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.84948160 |
| 117 | regulation of gamma-delta T cell activation (GO:0046643) | 2.84379947 |
| 118 | cholesterol homeostasis (GO:0042632) | 2.84360857 |
| 119 | pinocytosis (GO:0006907) | 2.83545588 |
| 120 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.82706423 |
| 121 | bile acid and bile salt transport (GO:0015721) | 2.82477845 |
| 122 | * response to interferon-gamma (GO:0034341) | 2.82128981 |
| 123 | positive regulation of hemostasis (GO:1900048) | 2.81313948 |
| 124 | positive regulation of blood coagulation (GO:0030194) | 2.81313948 |
| 125 | benzene-containing compound metabolic process (GO:0042537) | 2.80813818 |
| 126 | blood coagulation, intrinsic pathway (GO:0007597) | 2.80771329 |
| 127 | sterol homeostasis (GO:0055092) | 2.80314743 |
| 128 | protein-lipid complex assembly (GO:0065005) | 2.80223044 |
| 129 | phospholipid homeostasis (GO:0055091) | 2.79132269 |
| 130 | * response to interferon-alpha (GO:0035455) | 2.78879631 |
| 131 | cellular biogenic amine catabolic process (GO:0042402) | 2.78078718 |
| 132 | amine catabolic process (GO:0009310) | 2.78078718 |
| 133 | indolalkylamine metabolic process (GO:0006586) | 2.77643129 |
| 134 | macrophage activation involved in immune response (GO:0002281) | 2.77042613 |
| 135 | modulation by symbiont of host defense response (GO:0052031) | 2.76652957 |
| 136 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.76652957 |
| 137 | modulation by symbiont of host immune response (GO:0052553) | 2.76652957 |
| 138 | detection of external biotic stimulus (GO:0098581) | 2.74132517 |
| 139 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.73644935 |
| 140 | positive regulation of defense response to virus by host (GO:0002230) | 2.73041694 |
| 141 | positive regulation of lymphocyte migration (GO:2000403) | 2.72876872 |
| 142 | negative regulation of innate immune response (GO:0045824) | 2.72357175 |
| 143 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.71369645 |
| 144 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.71369645 |
| 145 | positive regulation by symbiont of host defense response (GO:0052509) | 2.71369645 |
| 146 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.69763802 |
| 147 | positive thymic T cell selection (GO:0045059) | 2.69321662 |
| 148 | response to protozoan (GO:0001562) | 2.64954729 |
| 149 | regulation of lymphocyte migration (GO:2000401) | 2.63933211 |
| 150 | defense response to protozoan (GO:0042832) | 2.63492471 |
| 151 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.61861204 |
| 152 | cytidine metabolic process (GO:0046087) | 2.58723825 |
| 153 | cytidine catabolic process (GO:0006216) | 2.58723825 |
| 154 | cytidine deamination (GO:0009972) | 2.58723825 |
| 155 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.58436631 |
| 156 | regulation of B cell differentiation (GO:0045577) | 2.57957451 |
| 157 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.57456605 |
| 158 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.56714789 |
| 159 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.54971559 |
| 160 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.52720675 |
| 161 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.50804991 |
| 162 | myeloid cell activation involved in immune response (GO:0002275) | 2.49064905 |
| 163 | cellular response to exogenous dsRNA (GO:0071360) | 2.48861131 |
| 164 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.47804520 |
| 165 | negative regulation of type I interferon production (GO:0032480) | 2.47015353 |
| 166 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.43917305 |
| 167 | cellular response to virus (GO:0098586) | 2.43691505 |
| 168 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.43139224 |
| 169 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.42836360 |
| 170 | regulation of superoxide anion generation (GO:0032928) | 2.42580122 |
| 171 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.42570329 |
| 172 | amino sugar catabolic process (GO:0046348) | 2.42136845 |
| 173 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.39964213 |
| 174 | positive regulation of T cell migration (GO:2000406) | 2.39707482 |
| 175 | * defense response to virus (GO:0051607) | 2.39617994 |
| 176 | regulation of T cell migration (GO:2000404) | 2.39592851 |
| 177 | lymphocyte migration (GO:0072676) | 2.39034842 |
| 178 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.38993246 |
| 179 | detection of biotic stimulus (GO:0009595) | 2.38392564 |
| 180 | positive regulation of type 2 immune response (GO:0002830) | 2.38038810 |
| 181 | germinal center formation (GO:0002467) | 2.37899548 |
| 182 | response to muramyl dipeptide (GO:0032495) | 2.37384197 |
| 183 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.36478162 |
| 184 | dendritic cell differentiation (GO:0097028) | 2.36370932 |
| 185 | respiratory burst (GO:0045730) | 2.35646595 |
| 186 | * regulation of viral genome replication (GO:0045069) | 2.35248697 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.89967347 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.81710782 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.80838890 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.37367766 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.06990449 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.64396837 |
| 7 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.60072424 |
| 8 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.47695745 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.40497677 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.20740521 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.79302549 |
| 12 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.70155468 |
| 13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.46782955 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.29305712 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.15392878 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.14014072 |
| 17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12270341 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.09574183 |
| 19 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.09406465 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.08955365 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.00642350 |
| 22 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.88425028 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 1.85668743 |
| 24 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.85375509 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.85101706 |
| 26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.82313943 |
| 27 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.81797413 |
| 28 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.79038128 |
| 29 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.72890313 |
| 30 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.65381405 |
| 31 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.64178044 |
| 32 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62232744 |
| 33 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.60764714 |
| 34 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.60037018 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.59343657 |
| 36 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.59153068 |
| 37 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57841771 |
| 38 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.54876496 |
| 39 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.54591672 |
| 40 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.53481673 |
| 41 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.49821775 |
| 42 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.46274220 |
| 43 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.46137631 |
| 44 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.45935932 |
| 45 | MAF_26560356_Chip-Seq_TH1_Human | 1.43842711 |
| 46 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.40153469 |
| 47 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.38346092 |
| 48 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.37479318 |
| 49 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.35358098 |
| 50 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.33623154 |
| 51 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.32654400 |
| 52 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.29205420 |
| 53 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.29097304 |
| 54 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.28927048 |
| 55 | MYC_22102868_ChIP-Seq_BL_Human | 1.28375915 |
| 56 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.28364798 |
| 57 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.24511967 |
| 58 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.23722223 |
| 59 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23664689 |
| 60 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22450245 |
| 61 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.21652876 |
| 62 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.20521327 |
| 63 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17210311 |
| 64 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.17158722 |
| 65 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.16922630 |
| 66 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.14646924 |
| 67 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.14531499 |
| 68 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.14466305 |
| 69 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12175536 |
| 70 | MYB_26560356_Chip-Seq_TH2_Human | 1.11674021 |
| 71 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.11386838 |
| 72 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.10696832 |
| 73 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.10205515 |
| 74 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09696976 |
| 75 | * MYB_26560356_Chip-Seq_TH1_Human | 1.09252718 |
| 76 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.07810769 |
| 77 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.07461068 |
| 78 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06834901 |
| 79 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.05109788 |
| 80 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.04244504 |
| 81 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03913004 |
| 82 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03770423 |
| 83 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02888913 |
| 84 | * P68_20966046_ChIP-Seq_HELA_Human | 1.02576865 |
| 85 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.02495833 |
| 86 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01785351 |
| 87 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.01641252 |
| 88 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.00427042 |
| 89 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.00204079 |
| 90 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99716494 |
| 91 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.98317571 |
| 92 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.97863246 |
| 93 | MAF_26560356_Chip-Seq_TH2_Human | 0.96634470 |
| 94 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.96532432 |
| 95 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.94935831 |
| 96 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.93387522 |
| 97 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.93193530 |
| 98 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.92693545 |
| 99 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91966347 |
| 100 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.91630182 |
| 101 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87715281 |
| 102 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.84702681 |
| 103 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.83450083 |
| 104 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83241787 |
| 105 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.82296501 |
| 106 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81945713 |
| 107 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.80715438 |
| 108 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80563750 |
| 109 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80275773 |
| 110 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79695599 |
| 111 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.79238917 |
| 112 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78834209 |
| 113 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.78589434 |
| 114 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.78079854 |
| 115 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.77778059 |
| 116 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.77645814 |
| 117 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.77482925 |
| 118 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.76744828 |
| 119 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.76514593 |
| 120 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.75523472 |
| 121 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.74289744 |
| 122 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.73725367 |
| 123 | SPI1_23127762_ChIP-Seq_K562_Human | 0.72385263 |
| 124 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71868393 |
| 125 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.71350145 |
| 126 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.71326905 |
| 127 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.70473363 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.95729390 |
| 2 | MP0005360_urolithiasis | 4.61840190 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 3.64625644 |
| 4 | MP0005365_abnormal_bile_salt | 3.58632994 |
| 5 | MP0009840_abnormal_foam_cell | 3.35757357 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 2.96181459 |
| 7 | MP0003191_abnormal_cellular_cholesterol | 2.75804376 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.61175100 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.56608859 |
| 10 | MP0003252_abnormal_bile_duct | 2.34630615 |
| 11 | MP0005083_abnormal_biliary_tract | 2.33820667 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.33297552 |
| 13 | MP0003436_decreased_susceptibility_to | 2.30910503 |
| 14 | MP0009785_altered_susceptibility_to | 2.27013340 |
| 15 | MP0003724_increased_susceptibility_to | 2.17671931 |
| 16 | MP0003763_abnormal_thymus_physiology | 2.04192864 |
| 17 | MP0000685_abnormal_immune_system | 1.98982584 |
| 18 | MP0006082_CNS_inflammation | 1.88872699 |
| 19 | MP0005058_abnormal_lysosome_morphology | 1.87137604 |
| 20 | MP0005025_abnormal_response_to | 1.84752817 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 1.82986618 |
| 22 | MP0000609_abnormal_liver_physiology | 1.78810335 |
| 23 | MP0003705_abnormal_hypodermis_morpholog | 1.78714654 |
| 24 | MP0003195_calcinosis | 1.74783753 |
| 25 | MP0003303_peritoneal_inflammation | 1.73238825 |
| 26 | MP0002419_abnormal_innate_immunity | 1.70439481 |
| 27 | MP0005464_abnormal_platelet_physiology | 1.65658788 |
| 28 | MP0008469_abnormal_protein_level | 1.61074287 |
| 29 | MP0001790_abnormal_immune_system | 1.56651478 |
| 30 | MP0005387_immune_system_phenotype | 1.56651478 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.55435043 |
| 32 | MP0005332_abnormal_amino_acid | 1.54026044 |
| 33 | MP0001666_abnormal_nutrient_absorption | 1.52813895 |
| 34 | MP0009764_decreased_sensitivity_to | 1.52322882 |
| 35 | MP0005000_abnormal_immune_tolerance | 1.48914447 |
| 36 | MP0003186_abnormal_redox_activity | 1.45859509 |
| 37 | MP0001800_abnormal_humoral_immune | 1.45272770 |
| 38 | MP0004947_skin_inflammation | 1.43743128 |
| 39 | MP0002148_abnormal_hypersensitivity_rea | 1.40845390 |
| 40 | MP0001853_heart_inflammation | 1.39664485 |
| 41 | MP0002254_reproductive_system_inflammat | 1.39494384 |
| 42 | MP0002166_altered_tumor_susceptibility | 1.37662572 |
| 43 | MP0002452_abnormal_antigen_presenting | 1.36575171 |
| 44 | MP0002723_abnormal_immune_serum | 1.36114000 |
| 45 | MP0003300_gastrointestinal_ulcer | 1.35438887 |
| 46 | MP0000604_amyloidosis | 1.34560255 |
| 47 | MP0002118_abnormal_lipid_homeostasis | 1.34302046 |
| 48 | MP0004019_abnormal_vitamin_homeostasis | 1.30226726 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.29969137 |
| 50 | MP0001845_abnormal_inflammatory_respons | 1.29863355 |
| 51 | MP0004510_myositis | 1.29839861 |
| 52 | MP0008438_abnormal_cutaneous_collagen | 1.29441342 |
| 53 | MP0005671_abnormal_response_to | 1.26973720 |
| 54 | MP0009763_increased_sensitivity_to | 1.26942902 |
| 55 | MP0000598_abnormal_liver_morphology | 1.22162734 |
| 56 | MP0001873_stomach_inflammation | 1.18505528 |
| 57 | MP0010368_abnormal_lymphatic_system | 1.15672469 |
| 58 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.15668651 |
| 59 | MP0005165_increased_susceptibility_to | 1.14987472 |
| 60 | MP0010155_abnormal_intestine_physiology | 1.14498687 |
| 61 | MP0000343_altered_response_to | 1.14397093 |
| 62 | MP0003866_abnormal_defecation | 1.13948352 |
| 63 | MP0003656_abnormal_erythrocyte_physiolo | 1.13183037 |
| 64 | MP0001819_abnormal_immune_cell | 1.13149650 |
| 65 | MP0002420_abnormal_adaptive_immunity | 1.11459496 |
| 66 | MP0009643_abnormal_urine_homeostasis | 1.08786515 |
| 67 | MP0008260_abnormal_autophagy | 1.06181896 |
| 68 | MP0005023_abnormal_wound_healing | 1.05878944 |
| 69 | MP0001764_abnormal_homeostasis | 1.05446999 |
| 70 | MP0005397_hematopoietic_system_phenotyp | 1.04624055 |
| 71 | MP0001545_abnormal_hematopoietic_system | 1.04624055 |
| 72 | MP0005310_abnormal_salivary_gland | 1.04374281 |
| 73 | MP0002006_tumorigenesis | 1.03519493 |
| 74 | MP0000858_altered_metastatic_potential | 1.03435114 |
| 75 | MP0002877_abnormal_melanocyte_morpholog | 1.03248826 |
| 76 | MP0003075_altered_response_to | 1.01358435 |
| 77 | MP0000703_abnormal_thymus_morphology | 1.00483386 |
| 78 | MP0003172_abnormal_lysosome_physiology | 1.00257840 |
| 79 | MP0009333_abnormal_splenocyte_physiolog | 1.00045985 |
| 80 | MP0003448_altered_tumor_morphology | 0.99764495 |
| 81 | MP0002132_abnormal_respiratory_system | 0.98920774 |
| 82 | MP0002405_respiratory_system_inflammati | 0.96656982 |
| 83 | MP0000689_abnormal_spleen_morphology | 0.93801389 |
| 84 | MP0000716_abnormal_immune_system | 0.93598635 |
| 85 | MP0003183_abnormal_peptide_metabolism | 0.92352794 |
| 86 | MP0009278_abnormal_bone_marrow | 0.91660565 |
| 87 | MP0003011_delayed_dark_adaptation | 0.91047675 |
| 88 | MP0004808_abnormal_hematopoietic_stem | 0.88551324 |
| 89 | MP0004782_abnormal_surfactant_physiolog | 0.86844761 |
| 90 | MP0000249_abnormal_blood_vessel | 0.86649835 |
| 91 | MP0002398_abnormal_bone_marrow | 0.86034383 |
| 92 | MP0000490_abnormal_crypts_of | 0.83869533 |
| 93 | MP0002019_abnormal_tumor_incidence | 0.83850842 |
| 94 | MP0002429_abnormal_blood_cell | 0.82981906 |
| 95 | MP0005164_abnormal_response_to | 0.82835673 |
| 96 | MP0005451_abnormal_body_composition | 0.82199040 |
| 97 | MP0002722_abnormal_immune_system | 0.81814590 |
| 98 | MP0003566_abnormal_cell_adhesion | 0.81146882 |
| 99 | MP0006054_spinal_hemorrhage | 0.81060785 |
| 100 | MP0003868_abnormal_feces_composition | 0.78992330 |
| 101 | MP0002396_abnormal_hematopoietic_system | 0.78981296 |
| 102 | MP0003453_abnormal_keratinocyte_physiol | 0.78817997 |
| 103 | MP0005166_decreased_susceptibility_to | 0.76800511 |
| 104 | MP0005390_skeleton_phenotype | 0.76229325 |
| 105 | MP0009642_abnormal_blood_homeostasis | 0.74197546 |
| 106 | MP0001881_abnormal_mammary_gland | 0.74073403 |
| 107 | MP0002998_abnormal_bone_remodeling | 0.73345491 |
| 108 | MP0005167_abnormal_blood-brain_barrier | 0.73078868 |
| 109 | MP0009697_abnormal_copulation | 0.72822255 |
| 110 | MP0010307_abnormal_tumor_latency | 0.72277352 |
| 111 | MP0002136_abnormal_kidney_physiology | 0.71885652 |
| 112 | MP0006036_abnormal_mitochondrial_physio | 0.71545164 |
| 113 | MP0002933_joint_inflammation | 0.71256061 |
| 114 | MP0001851_eye_inflammation | 0.69616687 |
| 115 | MP0008873_increased_physiological_sensi | 0.69415145 |
| 116 | MP0010352_gastrointestinal_tract_polyps | 0.67664858 |
| 117 | MP0000465_gastrointestinal_hemorrhage | 0.65688086 |
| 118 | MP0003045_fibrosis | 0.65431406 |
| 119 | MP0003795_abnormal_bone_structure | 0.63897502 |
| 120 | MP0008874_decreased_physiological_sensi | 0.63678327 |
| 121 | MP0001663_abnormal_digestive_system | 0.63014036 |
| 122 | MP0003690_abnormal_glial_cell | 0.61762832 |
| 123 | MP0009765_abnormal_xenobiotic_induced | 0.61716728 |
| 124 | MP0008004_abnormal_stomach_pH | 0.54415377 |
| 125 | MP0003329_amyloid_beta_deposits | 0.53752739 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.46055739 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.90387848 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 4.68486487 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.68486487 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.68486487 |
| 6 | Intrahepatic cholestasis (HP:0001406) | 4.67492739 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.67169930 |
| 8 | Complement deficiency (HP:0004431) | 4.62151930 |
| 9 | Xanthomatosis (HP:0000991) | 4.59903170 |
| 10 | Prolonged partial thromboplastin time (HP:0003645) | 4.28288947 |
| 11 | Joint hemorrhage (HP:0005261) | 4.14454225 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 4.06148497 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 4.04966034 |
| 14 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.90262898 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 3.86763331 |
| 16 | Abnormality of complement system (HP:0005339) | 3.71973104 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 3.66337438 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 3.53747645 |
| 19 | Myocardial infarction (HP:0001658) | 3.42831744 |
| 20 | Eczematoid dermatitis (HP:0000976) | 3.22704747 |
| 21 | Recurrent viral infections (HP:0004429) | 3.20417587 |
| 22 | Meningitis (HP:0001287) | 3.18235601 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 3.17963891 |
| 24 | Obstructive lung disease (HP:0006536) | 3.17963891 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.12032609 |
| 26 | Hypolipoproteinemia (HP:0010981) | 3.08988853 |
| 27 | Orchitis (HP:0100796) | 3.08289001 |
| 28 | Recurrent bacterial skin infections (HP:0005406) | 3.02267559 |
| 29 | Epidermoid cyst (HP:0200040) | 3.01442159 |
| 30 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.99444138 |
| 31 | Glomerulonephritis (HP:0000099) | 2.98000874 |
| 32 | Hypercholesterolemia (HP:0003124) | 2.97076589 |
| 33 | Hyperammonemia (HP:0001987) | 2.96544708 |
| 34 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.96389192 |
| 35 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.94488710 |
| 36 | Recurrent fungal infections (HP:0002841) | 2.93769313 |
| 37 | Agammaglobulinemia (HP:0004432) | 2.93159578 |
| 38 | Chronic otitis media (HP:0000389) | 2.90231901 |
| 39 | Increased IgM level (HP:0003496) | 2.88875888 |
| 40 | Gingival bleeding (HP:0000225) | 2.83523097 |
| 41 | Abnormality of the intrinsic pathway (HP:0010989) | 2.82569184 |
| 42 | Fat malabsorption (HP:0002630) | 2.81558274 |
| 43 | Stomatitis (HP:0010280) | 2.80093973 |
| 44 | Esophageal varix (HP:0002040) | 2.80084938 |
| 45 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.79684051 |
| 46 | Vasculitis (HP:0002633) | 2.79477993 |
| 47 | Hypoalphalipoproteinemia (HP:0003233) | 2.79000566 |
| 48 | Recurrent abscess formation (HP:0002722) | 2.78879168 |
| 49 | Retrobulbar optic neuritis (HP:0100654) | 2.78416380 |
| 50 | Optic neuritis (HP:0100653) | 2.78416380 |
| 51 | Autoimmune hemolytic anemia (HP:0001890) | 2.75061074 |
| 52 | Hepatosplenomegaly (HP:0001433) | 2.72400087 |
| 53 | Abnormality of the nasal mucosa (HP:0000433) | 2.71970304 |
| 54 | Pulmonary infiltrates (HP:0002113) | 2.66474443 |
| 55 | Petechiae (HP:0000967) | 2.66315596 |
| 56 | Vacuolated lymphocytes (HP:0001922) | 2.65740184 |
| 57 | Recurrent cutaneous fungal infections (HP:0011370) | 2.64559442 |
| 58 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.64559442 |
| 59 | Encephalitis (HP:0002383) | 2.58623100 |
| 60 | Autoimmune thrombocytopenia (HP:0001973) | 2.56692280 |
| 61 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.56208955 |
| 62 | Abnormality of iron homeostasis (HP:0011031) | 2.52783182 |
| 63 | Spastic diplegia (HP:0001264) | 2.52566022 |
| 64 | Hypergammaglobulinemia (HP:0010702) | 2.51900496 |
| 65 | Abnormality of methionine metabolism (HP:0010901) | 2.51657280 |
| 66 | Nasal polyposis (HP:0100582) | 2.49969210 |
| 67 | Gastrointestinal stroma tumor (HP:0100723) | 2.45882807 |
| 68 | Nephritis (HP:0000123) | 2.44718108 |
| 69 | Abnormality of macrophages (HP:0004311) | 2.44636407 |
| 70 | T lymphocytopenia (HP:0005403) | 2.44057357 |
| 71 | Colitis (HP:0002583) | 2.44003103 |
| 72 | Abnormality of T cells (HP:0002843) | 2.43917241 |
| 73 | Increased serum ferritin (HP:0003281) | 2.43892458 |
| 74 | Increased IgE level (HP:0003212) | 2.41865092 |
| 75 | Amyloidosis (HP:0011034) | 2.40951038 |
| 76 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.39941822 |
| 77 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.39124021 |
| 78 | Cellulitis (HP:0100658) | 2.38313135 |
| 79 | Abnormality of T cell number (HP:0011839) | 2.38264855 |
| 80 | Spontaneous hematomas (HP:0007420) | 2.37967685 |
| 81 | Recurrent bronchitis (HP:0002837) | 2.37800326 |
| 82 | Interstitial pulmonary disease (HP:0006530) | 2.36707263 |
| 83 | Hemorrhage of the eye (HP:0011885) | 2.36450705 |
| 84 | Menorrhagia (HP:0000132) | 2.36021483 |
| 85 | Abnormality of nucleobase metabolism (HP:0010932) | 2.35685012 |
| 86 | Hypertensive crisis (HP:0100735) | 2.35506178 |
| 87 | Ketosis (HP:0001946) | 2.35376199 |
| 88 | Steatorrhea (HP:0002570) | 2.35339154 |
| 89 | Myositis (HP:0100614) | 2.30559898 |
| 90 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.30114770 |
| 91 | Thrombophlebitis (HP:0004418) | 2.29725354 |
| 92 | Hypoglycemic coma (HP:0001325) | 2.29422028 |
| 93 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.29351127 |
| 94 | Epistaxis (HP:0000421) | 2.28897733 |
| 95 | Tetraparesis (HP:0002273) | 2.28805219 |
| 96 | Panhypogammaglobulinemia (HP:0003139) | 2.28800733 |
| 97 | Abnormality of T cell physiology (HP:0011840) | 2.28657854 |
| 98 | Increased cerebral lipofuscin (HP:0011813) | 2.28480178 |
| 99 | Peritonitis (HP:0002586) | 2.27751831 |
| 100 | Recurrent skin infections (HP:0001581) | 2.26509282 |
| 101 | IgM deficiency (HP:0002850) | 2.23988329 |
| 102 | Axonal loss (HP:0003447) | 2.23445019 |
| 103 | Spontaneous abortion (HP:0005268) | 2.23148916 |
| 104 | Hyperbilirubinemia (HP:0002904) | 2.22468922 |
| 105 | Hepatocellular carcinoma (HP:0001402) | 2.22459726 |
| 106 | Progressive neurologic deterioration (HP:0002344) | 2.21740968 |
| 107 | Polycythemia (HP:0001901) | 2.21360481 |
| 108 | Granulocytopenia (HP:0001913) | 2.20169163 |
| 109 | Purpura (HP:0000979) | 2.20093806 |
| 110 | Ragged-red muscle fibers (HP:0003200) | 2.17187637 |
| 111 | Hyperglycinemia (HP:0002154) | 2.16157851 |
| 112 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.15763839 |
| 113 | Vertebral compression fractures (HP:0002953) | 2.15477924 |
| 114 | Mitral stenosis (HP:0001718) | 2.15407945 |
| 115 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.12655998 |
| 116 | Pulmonary embolism (HP:0002204) | 2.11250373 |
| 117 | Abnormality of the prostate (HP:0008775) | 2.10093181 |
| 118 | Skin nodule (HP:0200036) | 2.09257804 |
| 119 | Skin rash (HP:0000988) | 2.08805250 |
| 120 | Mucopolysacchariduria (HP:0008155) | 2.08151843 |
| 121 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.08151843 |
| 122 | Polygenic inheritance (HP:0010982) | 2.07936855 |
| 123 | Gastrointestinal inflammation (HP:0004386) | 2.07540707 |
| 124 | Abnormality of purine metabolism (HP:0004352) | 2.05332921 |
| 125 | Inflammation of the large intestine (HP:0002037) | 2.05099331 |
| 126 | Abnormal platelet volume (HP:0011876) | 2.03651626 |
| 127 | Hyperglycinuria (HP:0003108) | 2.03576779 |
| 128 | IgG deficiency (HP:0004315) | 2.03519168 |
| 129 | Abnormal platelet function (HP:0011869) | 2.02802860 |
| 130 | Impaired platelet aggregation (HP:0003540) | 2.02802860 |
| 131 | Lymphopenia (HP:0001888) | 2.02624844 |
| 132 | Conjunctival telangiectasia (HP:0000524) | 2.01778958 |
| 133 | Nausea (HP:0002018) | 2.01610094 |
| 134 | Pustule (HP:0200039) | 2.01319333 |
| 135 | Gingivitis (HP:0000230) | 2.01159052 |
| 136 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.00671058 |
| 137 | Hemoptysis (HP:0002105) | 2.00528092 |
| 138 | Prolonged neonatal jaundice (HP:0006579) | 2.00338146 |
| 139 | Increased mean platelet volume (HP:0011877) | 1.99208352 |
| 140 | Dysostosis multiplex (HP:0000943) | 1.99136916 |
| 141 | Abnormal gallbladder physiology (HP:0012438) | 1.97157095 |
| 142 | Cholecystitis (HP:0001082) | 1.97157095 |
| 143 | Thrombocytosis (HP:0001894) | 1.96825309 |
| 144 | Loss of speech (HP:0002371) | 1.96775728 |
| 145 | IgA deficiency (HP:0002720) | 1.96577190 |
| 146 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.96526486 |
| 147 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.96417641 |
| 148 | Vascular calcification (HP:0004934) | 1.95567534 |
| 149 | Abnormality of glycine metabolism (HP:0010895) | 1.94763314 |
| 150 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.94763314 |
| 151 | Urticaria (HP:0001025) | 1.94479885 |
| 152 | Keratoconjunctivitis sicca (HP:0001097) | 1.93681655 |
| 153 | Conjugated hyperbilirubinemia (HP:0002908) | 1.93118296 |
| 154 | Gangrene (HP:0100758) | 1.92566649 |
| 155 | Chest pain (HP:0100749) | 1.92091550 |
| 156 | Chronic diarrhea (HP:0002028) | 1.91829303 |
| 157 | Joint swelling (HP:0001386) | 1.91036852 |
| 158 | Acute hepatic failure (HP:0006554) | 1.90899298 |
| 159 | Abnormality of proline metabolism (HP:0010907) | 1.90077054 |
| 160 | Hydroxyprolinuria (HP:0003080) | 1.90077054 |
| 161 | Arterial thrombosis (HP:0004420) | 1.90029505 |
| 162 | Reduced antithrombin III activity (HP:0001976) | 1.90008127 |
| 163 | Abnormality of the pleura (HP:0002103) | 1.89709012 |
| 164 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.89121161 |
| 165 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.89121161 |
| 166 | Gastrointestinal infarctions (HP:0005244) | 1.88220370 |
| 167 | Recurrent sinusitis (HP:0011108) | 1.84545894 |
| 168 | Arthralgia (HP:0002829) | 1.83231261 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.16602287 |
| 2 | TYK2 | 3.57791702 |
| 3 | FGFR4 | 3.53079069 |
| 4 | TBK1 | 3.40088286 |
| 5 | KIT | 2.69946614 |
| 6 | IKBKE | 2.60247656 |
| 7 | BCKDK | 2.53789645 |
| 8 | PKN2 | 2.48355338 |
| 9 | TRIB3 | 2.48128947 |
| 10 | MAP4K1 | 2.47049577 |
| 11 | VRK2 | 2.32562789 |
| 12 | RIPK4 | 2.30682842 |
| 13 | MAP3K14 | 2.27399641 |
| 14 | NME2 | 2.25141268 |
| 15 | KDR | 2.22420117 |
| 16 | JAK3 | 2.17479389 |
| 17 | BLK | 2.06609971 |
| 18 | TGFBR2 | 1.98805287 |
| 19 | JAK1 | 1.88258126 |
| 20 | TESK1 | 1.85084375 |
| 21 | TAOK2 | 1.80967023 |
| 22 | FLT3 | 1.76117813 |
| 23 | SIK1 | 1.75574259 |
| 24 | PRPF4B | 1.74833335 |
| 25 | TAOK3 | 1.68271405 |
| 26 | IRAK3 | 1.63559266 |
| 27 | EPHB1 | 1.56938420 |
| 28 | MAP2K3 | 1.53404211 |
| 29 | ZAP70 | 1.51284335 |
| 30 | IKBKB | 1.51204085 |
| 31 | RPS6KA4 | 1.49398331 |
| 32 | ARAF | 1.48073680 |
| 33 | PIM2 | 1.44893095 |
| 34 | LRRK2 | 1.44044144 |
| 35 | NEK9 | 1.41571853 |
| 36 | CSK | 1.39307584 |
| 37 | TIE1 | 1.38265775 |
| 38 | SMG1 | 1.33699236 |
| 39 | PTK6 | 1.33171544 |
| 40 | CSF1R | 1.27342859 |
| 41 | IRAK4 | 1.21784258 |
| 42 | ABL2 | 1.17246846 |
| 43 | JAK2 | 1.16295079 |
| 44 | BTK | 1.14017521 |
| 45 | FGFR3 | 1.13788216 |
| 46 | STK10 | 1.11779186 |
| 47 | EEF2K | 1.04989048 |
| 48 | DAPK1 | 1.03429997 |
| 49 | MAPK11 | 1.03250109 |
| 50 | MAP3K3 | 1.02120273 |
| 51 | EPHA3 | 1.01502303 |
| 52 | MAP3K10 | 1.00979083 |
| 53 | TGFBR1 | 1.00063843 |
| 54 | BMPR2 | 0.95674615 |
| 55 | CHUK | 0.90939159 |
| 56 | GRK7 | 0.90936257 |
| 57 | BMX | 0.89883505 |
| 58 | CDK6 | 0.89392726 |
| 59 | GRK6 | 0.87083357 |
| 60 | PIM1 | 0.85284015 |
| 61 | HCK | 0.85214882 |
| 62 | SYK | 0.83740755 |
| 63 | TNK2 | 0.83224414 |
| 64 | MAP3K13 | 0.81762872 |
| 65 | TXK | 0.81525354 |
| 66 | TEC | 0.81424877 |
| 67 | MATK | 0.79960037 |
| 68 | MAP3K11 | 0.78480503 |
| 69 | RIPK1 | 0.77994546 |
| 70 | MST1R | 0.77258438 |
| 71 | PAK4 | 0.76493481 |
| 72 | LCK | 0.75057105 |
| 73 | PBK | 0.74294758 |
| 74 | LYN | 0.70209405 |
| 75 | TTN | 0.69223066 |
| 76 | PDK2 | 0.66821327 |
| 77 | PIK3CG | 0.65650247 |
| 78 | CDK4 | 0.63087101 |
| 79 | MAPK4 | 0.60513560 |
| 80 | ERBB4 | 0.60491059 |
| 81 | HIPK2 | 0.59702005 |
| 82 | MAP3K8 | 0.59661024 |
| 83 | EGFR | 0.58262909 |
| 84 | FES | 0.57980175 |
| 85 | PRKCQ | 0.54799426 |
| 86 | MST4 | 0.54714412 |
| 87 | ITK | 0.53842961 |
| 88 | SCYL2 | 0.53466014 |
| 89 | TLK1 | 0.52227535 |
| 90 | ABL1 | 0.51647172 |
| 91 | EPHA2 | 0.50932969 |
| 92 | PRKG2 | 0.48676916 |
| 93 | DYRK1B | 0.46373854 |
| 94 | LIMK1 | 0.46161535 |
| 95 | SIK3 | 0.44033057 |
| 96 | MAP2K6 | 0.43444266 |
| 97 | TAOK1 | 0.43420859 |
| 98 | MOS | 0.43192436 |
| 99 | DAPK3 | 0.43071577 |
| 100 | STK16 | 0.42980003 |
| 101 | VRK1 | 0.42951328 |
| 102 | MAPKAPK3 | 0.42580331 |
| 103 | TESK2 | 0.41115063 |
| 104 | RPS6KB2 | 0.40093360 |
| 105 | PDGFRA | 0.39134437 |
| 106 | MARK3 | 0.39095281 |
| 107 | CAMK1D | 0.36500663 |
| 108 | PAK1 | 0.35235142 |
| 109 | PTK2 | 0.34691152 |
| 110 | NLK | 0.34307737 |
| 111 | CDC42BPA | 0.33809826 |
| 112 | PRKCD | 0.32394731 |
| 113 | PDK1 | 0.32139576 |
| 114 | GSK3A | 0.31923733 |
| 115 | AURKA | 0.31529846 |
| 116 | MAP3K5 | 0.30815706 |
| 117 | PAK2 | 0.30726474 |
| 118 | STK4 | 0.30527692 |
| 119 | RPS6KA6 | 0.29600898 |
| 120 | MAPK7 | 0.28888597 |
| 121 | MAPKAPK2 | 0.28853671 |
| 122 | CCNB1 | 0.28762718 |
| 123 | PDPK1 | 0.28398153 |
| 124 | MAP3K1 | 0.27947070 |
| 125 | FGR | 0.26500128 |
| 126 | MAPK12 | 0.26223092 |
| 127 | MAP2K2 | 0.24873753 |
| 128 | MAPK3 | 0.24110797 |
| 129 | IGF1R | 0.23883562 |
| 130 | RPS6KA5 | 0.23211792 |
| 131 | IRAK1 | 0.22978686 |
| 132 | ACVR1B | 0.22839920 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.00804249 |
| 2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.43985282 |
| 3 | Asthma_Homo sapiens_hsa05310 | 3.11660020 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.07209658 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.01538589 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.97591397 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.96222214 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.65349821 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.59934475 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.51304040 |
| 11 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.46018220 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.25036500 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.19498389 |
| 14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.09040830 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.03513352 |
| 16 | Proteasome_Homo sapiens_hsa03050 | 2.03449353 |
| 17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.95347429 |
| 18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.83441120 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.83066654 |
| 20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.81927116 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.78382099 |
| 22 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.73791941 |
| 23 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.66745750 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.64169707 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.57709335 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.57168189 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.55757758 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.48779461 |
| 29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.40757927 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.39968156 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.32794669 |
| 32 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.29023620 |
| 33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.28837954 |
| 34 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.27089793 |
| 35 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.26613493 |
| 36 | Sulfur relay system_Homo sapiens_hsa04122 | 1.26529792 |
| 37 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.26150229 |
| 38 | Leishmaniasis_Homo sapiens_hsa05140 | 1.24757370 |
| 39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.24430763 |
| 40 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.15616079 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.15039838 |
| 42 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.12839324 |
| 43 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.08067649 |
| 44 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.07992624 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.06689868 |
| 46 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.06591643 |
| 47 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.06345362 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.04659481 |
| 49 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.02178011 |
| 50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.01878784 |
| 51 | Bile secretion_Homo sapiens_hsa04976 | 1.01473520 |
| 52 | Phagosome_Homo sapiens_hsa04145 | 1.01172233 |
| 53 | Salmonella infection_Homo sapiens_hsa05132 | 1.00804850 |
| 54 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.00259656 |
| 55 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.97715338 |
| 56 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.97408320 |
| 57 | Measles_Homo sapiens_hsa05162 | 0.97116286 |
| 58 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.96799538 |
| 59 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.95007482 |
| 60 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.94237344 |
| 61 | Pertussis_Homo sapiens_hsa05133 | 0.94211384 |
| 62 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.93197152 |
| 63 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.92986407 |
| 64 | Malaria_Homo sapiens_hsa05144 | 0.92765366 |
| 65 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.92039014 |
| 66 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.91612567 |
| 67 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.91345811 |
| 68 | Carbon metabolism_Homo sapiens_hsa01200 | 0.90091730 |
| 69 | Legionellosis_Homo sapiens_hsa05134 | 0.87087555 |
| 70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.84671591 |
| 71 | Ribosome_Homo sapiens_hsa03010 | 0.81323797 |
| 72 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.81259419 |
| 73 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.79763610 |
| 74 | Lysosome_Homo sapiens_hsa04142 | 0.79444129 |
| 75 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.76063934 |
| 76 | Influenza A_Homo sapiens_hsa05164 | 0.74501832 |
| 77 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.71804581 |
| 78 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.71380112 |
| 79 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.70056616 |
| 80 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.69017436 |
| 81 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.68403621 |
| 82 | Other glycan degradation_Homo sapiens_hsa00511 | 0.68220052 |
| 83 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.68132561 |
| 84 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.66786528 |
| 85 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.65705129 |
| 86 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.65641997 |
| 87 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.65580961 |
| 88 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.63362032 |
| 89 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.60893020 |
| 90 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.60369660 |
| 91 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.60155696 |
| 92 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.59452097 |
| 93 | DNA replication_Homo sapiens_hsa03030 | 0.59140840 |
| 94 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.59040623 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58926207 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | 0.58803337 |
| 97 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.56633878 |
| 98 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.56060543 |
| 99 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.56038576 |
| 100 | Prion diseases_Homo sapiens_hsa05020 | 0.55322819 |
| 101 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.54616638 |
| 102 | Tuberculosis_Homo sapiens_hsa05152 | 0.54107813 |
| 103 | Base excision repair_Homo sapiens_hsa03410 | 0.53716371 |
| 104 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52771314 |
| 105 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52407738 |
| 106 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.52292186 |
| 107 | Apoptosis_Homo sapiens_hsa04210 | 0.51815988 |
| 108 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50808645 |
| 109 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50471199 |
| 110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50206127 |
| 111 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.49847199 |
| 112 | Lysine degradation_Homo sapiens_hsa00310 | 0.48859929 |
| 113 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.48457335 |
| 114 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.45413449 |
| 115 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45015221 |
| 116 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44268921 |
| 117 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.43922034 |
| 118 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.43837775 |
| 119 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.41773772 |
| 120 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.40451453 |
| 121 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.39906365 |
| 122 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39686169 |
| 123 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.39124609 |
| 124 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.36982885 |
| 125 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.36471417 |
| 126 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.35751568 |
| 127 | Allograft rejection_Homo sapiens_hsa05330 | 0.35598755 |
| 128 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.35557554 |
| 129 | Shigellosis_Homo sapiens_hsa05131 | 0.33885774 |
| 130 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.33693140 |
| 131 | Insulin resistance_Homo sapiens_hsa04931 | 0.32378685 |
| 132 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32110871 |
| 133 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.30873788 |
| 134 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.30808376 |
| 135 | Hepatitis B_Homo sapiens_hsa05161 | 0.30077908 |
| 136 | Bladder cancer_Homo sapiens_hsa05219 | 0.28813653 |
| 137 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.27333609 |
| 138 | Parkinsons disease_Homo sapiens_hsa05012 | 0.24713991 |

